Skip to content
Subscriber Only

Dealmakers Are Off to Hottest Start of the Year Since 2000

  • Executives are buoyed by strong economies, stock markets
  • Passage of tax overhaul bill eliminated some CEO uncertainty
Video player cover image
Bloomberg Gadfly columnist Max Nisen says recent biotech mergers may wind up being duds.(Source: Bloomberg)
Updated on

From pharma to finance, dealmaking in 2018 is on fire around the globe.

Just three weeks into the year, the value of mergers announced totals $152.5 billion. That’s the highest since the $374 billion racked up in the same period during the technology deal frenzy in 2000, according to data compiled by Bloomberg. While clouds loom, bankers say the U.S. corporate tax cut, robust economies and rising stock markets are giving executives confidence to sign off on billion-dollar transactions -- and in some cases, to pay rich prices.